# Urokinase for Thrombolysis in Acute Ischemic Stroke

> **NCT07047326** · NA · RECRUITING · sponsor: **Capital Medical University** · enrollment: 24 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Urokinase thrombolysis

## Key facts

- **NCT ID:** NCT07047326
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-10-02
- **Final completion:** 2027-01-02
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07047326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07047326, "Urokinase for Thrombolysis in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT07047326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*